Insider Selling: Addus HomeCare (NASDAQ:ADUS) EVP Sells $46,569.12 in Stock

Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) EVP Sean Gaffney sold 442 shares of the stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $46,569.12. Following the completion of the transaction, the executive vice president directly owned 20,080 shares in the company, valued at $2,115,628.80. This trade represents a 2.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Sean Gaffney also recently made the following trade(s):

  • On Tuesday, February 24th, Sean Gaffney sold 817 shares of Addus HomeCare stock. The shares were sold at an average price of $106.98, for a total value of $87,402.66.

Addus HomeCare Stock Down 0.5%

Shares of NASDAQ ADUS opened at $103.53 on Friday. The business has a 50-day moving average of $109.22 and a two-hundred day moving average of $112.95. The company has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $124.43. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.66.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ADUS. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday, February 23rd. Stephens dropped their target price on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $134.33.

View Our Latest Report on ADUS

Key Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

  • Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
  • Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
  • Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
  • Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
  • Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
  • Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds have recently made changes to their positions in ADUS. Hohimer Wealth Management LLC grew its holdings in shares of Addus HomeCare by 3.4% during the third quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock worth $320,000 after buying an additional 88 shares during the last quarter. Ameritas Investment Partners Inc. raised its stake in Addus HomeCare by 5.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company’s stock valued at $214,000 after acquiring an additional 89 shares during the last quarter. Amalgamated Bank lifted its position in Addus HomeCare by 1.8% during the 3rd quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock worth $618,000 after acquiring an additional 93 shares during the period. Oregon Public Employees Retirement Fund lifted its position in Addus HomeCare by 2.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after acquiring an additional 103 shares during the period. Finally, GAMMA Investing LLC grew its stake in shares of Addus HomeCare by 6.3% in the 3rd quarter. GAMMA Investing LLC now owns 1,778 shares of the company’s stock valued at $210,000 after purchasing an additional 105 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Further Reading

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.